Quiz|Articles|October 12, 2025
Dermatology Times Spot Test: October 12, 2025
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- Dermatology Times is focusing on the latest developments in vitiligo, emphasizing essential topics and breakthroughs.
- Weekly thought-provoking questions are designed to engage dermatology professionals and test their understanding.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Dermatology Times presents: Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology.
This week, we'll focus on the latest news in
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
Which systemic therapy is currently under investigation for vitiligo treatment?
In a recent study of the 308 nm Excimer Laser and JAK inhibitors, what was the relapse rate in the combination therapy group after 52 weeks?
In the latest research, what percentage of vitiligo patients reported experiencing stress?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
